Cabaletta Bio Inc
Change company Symbol lookup
Select an option...
CABA Cabaletta Bio Inc
ASLN Aslan Pharmaceuticals Ltd
SCBH Seacoast Commerce Banc Holdings
PHX Panhandle Oil and Gas Inc
BTU Peabody Energy Corp
CLNY Colony Capital Inc
BAC Bank of America Corp
USAK USA Truck Inc
BABA Alibaba Group Holding Ltd
CTL Centurylink Inc
Go

Company profile

Cabaletta Bio Inc. is a clinical stage biotechnology company. The Company is focused on discovery and development of engineered T-cell therapies for B cell-mediated autoimmune diseases. The T cells are designed to selectively bind and eliminate B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. The Company’s lead CAAR T cell product candidate are designed based on chimeric antigen receptor, and its T cell technology has been developed and is marketed for the treatment of B cell cancers. The Company has discovered and developed four product candidates, including its lead product candidate, to potentially treat patients with mucosal pemphigus vulgaris (mPV), and three additional product candidates that have demonstrated specific and selective target engagement in vitro. Its product pipelines include DSG3-CAART, DSG3/1-CAART, Musk-CAART and FVIII-CAART.

Closing Price
$16.17
Day's Change
-0.20 (-1.22%)
Bid
--
Ask
--
B/A Size
--
Day's High
16.63
Day's Low
15.90
Volume
(Light)
Volume:
51,014

10-day average volume:
93,435
51,014
  • Prev Close
    16.37
  • Today's Open
    16.28
  • Day's Range
    15.90-16.63
  • Avg Vol (10-day)
    93.4K
  • Last (time)
    4:00p ET 01/21/20
  • Last (size)
    1.6K
  • 52-Wk Range
    7.56 - 18.28
    LowHigh
  • (11/19/19 - 12/12/19)
    11.54%
  • 139.3%
  • Market Cap
    388.6M
  • Shares Outstanding
    24.0M
  • -0.83
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • --
  • 39.65
  • (% of float 12/31/19)
    0.74

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.